Description
Prolia® is a powerful tool in the battle against osteoporosis – a condition causing bones to weaken and become more susceptible to fractures. Factors like age, post-menopause (in women), family history of osteoporosis, and prolonged use of certain medications can elevate the risk of osteoporosis development.
How Prolia® Works:
Prolia® utilizes a RANK ligand inhibitor, denosumab injection, to address bone health concerns. By obstructing a specific receptor, bone breakdown is diminished, aiding in the prevention of fractures. Additionally, Prolia® tackles high calcium levels by curbing the release of calcium from bones during their breakdown.
Versatility and Effectiveness:
- Prolia® effectively manages corticosteroid-induced osteoporosis for individuals on extended treatment.
- It’s beneficial for men and women on corticosteroids for at least 6 months.
- Prolia® aids in bone loss prevention for men undergoing prostate cancer treatment.
- Women receiving specific medications for breast cancer can utilize Prolia® to combat bone loss and mitigate fracture risk.
Not a Diabetic Medication:
Prolia® is distinct from insulin and diabetic medications, focusing solely on enhancing bone health.
Reinforcing Bone Integrity: By curbing bone loss and preserving bone strength, Prolia® serves as a barrier against fractures. Denosumab, categorized as a monoclonal antibody, hinders osteoclasts – cells responsible for bone breakdown – from their destructive activities.
Reviews
There are no reviews yet.